![Brent Pfeiffenberger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 9 M $ in data 31/05/2026
Brent Pfeiffenberger is currently Chairman, President & Chief Executive Officer at Century Therapeutics, Inc. starting in 2025 and Independent Director at Corbus Pharmaceuticals Holdings, Inc. starting in 2026.
Former roles include Chief Operating Officer at Neogene Therapeutics, Inc. from 2021 to 2023 and Director at Medicines Australia.
Education includes an MBA from The Wharton School of the University of Pennsylvania and a doctorate from Duquesne University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 11/06/2026 | 3.665.474 ( 2,03% ) | 9 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Amministratore Delegato | 04/12/2023 |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | 13/05/2026 |
| Società | Posizione | Fine |
|---|---|---|
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Direttore operativo | 01/12/2023 |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Direttore/Membro del Consiglio | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Medicines Australia
Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corbus Pharmaceuticals Holdings, Inc.
 Corbus Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases | Health Technology |
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that provides TCR therapies targeting neo-antigens in solid cancers | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
